Andrographolide sulfonate alleviates rheumatoid arthritis by inhibiting glycolysis-mediated activation of PI3K/AKT to restrain Th17 cell differentiation

Abstract

Andrographolide sulfonate (AS) is a sulfonated derivative of andrographolide extracted from Andrographis paniculata (Burm.f.) Nees, and has been approved for several decades in China. The present study aimed to investigate the novel therapeutic application and possible mechanisms of AS in the treatment of rheumatoid arthritis. Results indicated that administration of AS by injection or gavage significantly reduced the paw swelling, improved body weights, and attenuated pathological changes in joints of rats with adjuvant-induced arthritis. Additionally, the levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-1β in the serum and ankle joints were reduced. Bioinformatics analysis, along with the spleen index and measurements of IL-17 and IL-10 levels, suggested a potential relationship between AS and Th17 cells under arthritic conditions. In vitro, AS was shown to block Th17 cell differentiation, as evidenced by the reduced percentages of CD4⁺ IL-17A⁺ T cells and decreased expression levels of RORγt, IL-17A, IL-17F, IL-21, and IL-22, without affecting the cell viability and apoptosis. This effect was attributed to the limited glycolysis, as indicated by metabolomics analysis, reduced glucose uptake, and pH measurements. Further investigation revealed that AS might bind to hexokinase2 (HK2) to down-regulate the protein levels of HK2 but not glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or pyruvate kinase M2 (PKM2), and overexpression of HK2 reversed the inhibition of AS on Th17 cell differentiation. Furthermore, AS impaired the activation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signals in vivo and in vitro, which was abolished by the addition of lactate. In conclusion, AS significantly improved adjuvant-induced arthritis (AIA) in rats by inhibiting glycolysis-mediated activation of PI3K/AKT to restrain Th17 cell differentiation.

Keywords

Andrographolide sulfonate / Rheumatoid arthritis / Th17 cell differentiation / Glycolysis / PI3K/AKT pathway

References

[1] Smith MH, Berman JR. What is rheumatoid arthritis? JAMA. 2022; 327(12):1194. https://doi.org/10.1001/jama.2022.0786.

[2] Pirmardvand Chegini S, Varshosaz J, Taymouri S. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment. Artif Cells Nanomed Biotechnol. 2018; 46(sup2):502-514. https://doi.org/10.1080/21691401.2018.1460373.

[3] Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016; 388(10055):2023-2038. https://doi.org/10.1016/S0140-6736(16)30173-8.

[4] Myasoedova E. New era for outcomes and management of rheumatoid arthritis: facing the individualized treatment challenge. Joint Bone Spine. 2021; 88(3):105066. https://doi.org/10.1016/j.jbspin.2020.08.001.

[5] Zingler G, Hermann B, Fischer T, et al. Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks. Expert Rev Clin Pharmacol. 2016; 9(11):1479-1492. https://doi.org/10.1080/17512433.2016.1230495.

[6] Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021; 10(11):2857. https://doi.org/10.3390/cells10112857.

[7] Hyndman IJ. Rheumatoid arthritis: past, present and future approaches to treating the disease. Int J Rheum Dis. 2017; 20(4):417-419. https://doi.org/10.1111/1756-185X.12823.

[8] Kumar S, Singh B, Bajpai V. Andrographis paniculata (Burm. f.) nees: traditional uses, phytochemistry, pharmacological properties and quality control/quality assurance. J Ethnopharmacol. 2021;275:114054. https://doi.org/10.1016/j.jep.2021.114054.

[9] Yen CC, Chen YC, Wu MT, et al. Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide. Int J Nanomed. 2018; 13:699-680. https://doi.org/10.2147/IJN.S154824.

[10] Guo W, Liu W, Chen G, et al. Water-soluble andrographolide sulfonate exerts anti-sepsis action in mice through down-regulating p38 MAPK, STAT3 and NF-κB pathways. Int Immunopharmacol. 2012; 14(4):613-619. https://doi.org/10.1016/j.intimp.2012.09.002.

[11] Gao J, Cui J, Zhong H, et al. Andrographolide sulfonate ameliorates chronic colitis induced by TNBS in mice via decreasing inflammation and fibrosis. Int Immunopharmacol. 2020;83:106426. https://doi.org/10.1016/j.intimp.2020.106426.

[12] Pan R, Dai Y, Gao X, et al. Scopolin isolated from Erycibe obtusifolia Benth stems suppresses adjuvant-induced rat arthritis by inhibiting inflammation and angiogenesis. Int Immunopharmacol. 2009; 9(7-8):859-869. https://doi.org/10.1016/j.intimp.2009.02.019.

[13] Jawed H, Shah SU, Jamall S, et al. N-(2-hydroxy phenyl) acetamide inhibits inflammation-related cytokines and ROS in adjuvant-induced arthritic (AIA) rats. Int Immunopharmacol. 2010; 10(8):900-905. https://doi.org/10.1016/j.intimp.2010.04.028.

[14] Yue M, Tao Y, Fang Y, et al. The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply. FASEB J. 2019; 33(11):12311-12323. https://doi.org/10.1096/fj.201900425RR.

[15] Guo F, Jiang C, Xi Y, et al. Investigation of pharmacological mechanism of natural product using pathway fingerprints similarity based on “drug-target-pathway” heterogenous network. J Cheminform. 2021; 13(1):68. https://doi.org/10.1186/s13321-021-00549-5.

[16] Xue X, Zeng X, Wu X, et al. SIRT4 protects against intestinal fibrosis by facilitating GLS1 degradation. Matrix Biol. 2023; 122:33-45. https://doi.org/10.1016/j.matbio.2023.08.001.

[17] Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022; 23(2):905. https://doi.org/10.3390/ijms23020905.

[18] Jin S, Chen H, Li Y, et al.Maresin 1 improves the Treg/Th 17 imbalance in rheumatoid arthritis through miR-21. Ann Rheum Dis. 2018; 77(11):1644-1652. https://doi.org/10.1136/annrheumdis-2018-213511.

[19] Yang P, Zhang M, Wang X, et al. MicroRNA let-7g-5p alleviates murine collagen-induced arthritis by inhibiting. Biochem Pharmacol. 2020;174:113822. https://doi.org/10.1016/j.bcp.2020.113822.

[20] Toghi M, Bitarafan S, Ghafouri-Fard S. Pathogenic Th 17 cells in autoimmunity with regard to rheumatoid arthritis. Pathol Res Pract. 2023;250:154818. https://doi.org/10.1016/j.prp.2023.154818.

[21] Peng HY, Lucavs J, Ballard D, et al. Metabolic reprogramming and reactive oxygen species in T cell immunity. Front Immunol. 2021;12:652687. https://doi.org/10.3389/fimmu.2021.652687.

[22] Bian X, Jiang H, Meng Y, et al. Regulation of gene expression by glycolytic and gluconeogenic enzymes. Trends Cell Biol. 2022; 32(9):786-799. https://doi.org/10.1016/j.tcb.2022.02.003.

[23] Fu S, Song X, Hu Y, et al. Neotuberostemonine and tuberostemonine ameliorate pulmonary fibrosis through suppressing TGF-β and SDF-1 secreted by macrophages and fibroblasts via the PI3K-dependent AKT and ERK pathways. Chin J Nat Med. 2023; 21(7):527-539. https://doi.org/10.1016/s1875-5364(23)60444-3.

[24] Woo YM, Shin Y, Lee EJ, et al. Inhibition of aerobic glycolysis represses Akt/mTOR/HIF-1α axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells. PLoS One. 2015; 10(7):e0132285. https://doi.org/10.1371/journal.pone.0132285.

[25] Feldmann M, Maini SR. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev. 2008; 223:7-19. https://doi.org/10.1111/j.1600-065X.2008.00626.x.

[26] Kohler BM, Gunther J, Kaudewitz D, et al. Current therapeutic options in the treatment of rheumatoid arthritis. J Clin Med. 2019; 8(7):938. https://doi.org/10.3390/jcm8070938.

[27] Mateen S, Zafar A, Moin S, et al. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta. 2016; 455:161-171. https://doi.org/10.1016/j.cca.2016.02.010.

[28] Pan H, Guo R, Ju Y, et al. A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis. Microbiome. 2019; 7(1):107. https://doi.org/10.1186/s40168-019-0719-1.

[29] Shao X, Zhang H, Rajian JR, et al. ¹²⁵I-labeled gold nanorods for targeted imaging of inflammation. ACS Nano. 2011; 5(11):8967-8973. https://doi.org/10.1021/nn203138t.

[30] Jiang Y, Wang X, Dong C. Molecular mechanisms of T helper 17 cell differentiation: emerging roles for transcription cofactors. Adv Immunol. 2019; 144:121-153. https://doi.org/10.1016/bs.ai.2019.09.003.

[31] Ruterbusch M, Pruner KB, Shehata L, et al. In vivo CD4⁺ T cell differentiation and function: revisiting the Th1/Th2 paradigm. Annu Rev Immunol. 2020; 38:705-725. https://doi.org/10.1146/annurev-immunol-103019-085803.

[32] Boissier MC, Assier E, Falgarone G, et al. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine. 2008; 75(4):373-375. https://doi.org/10.1016/j.jbspin.2008.04.005.

[33] Paradowska-Gorycka A, Wajda A, Romanowska-Próchnicka K, et al. Th17/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis. Front Immunol. 2020;11:572858. https://doi.org/10.3389/fimmu.2020.572858.

[34] Hui W, Yu D, Cao Z, et al. Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis. Int Immunopharmacol. 2019; 68:226-233. https://doi.org/10.1016/j.intimp.2019.01.018.

[35] Qiu J, Lu C, Zhang L, et al. Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors. Clin Rheumatol. 2022; 41(9):2685-2693. https://doi.org/10.1007/s10067-022-06212-0.

[36] Geltink RIK, Kyle RL, Pearce EL. Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol. 2018; 36:461-488. https://doi.org/10.1146/annurev-immunol-042617-053019.

[37] Gerriets VA, Kishton RJ, Nichols AG, et al. Metabolic programming and PDHK1 control CD4⁺ T cell subsets and inflammation. J Clin Invest. 2015; 125(1):194-207. https://doi.org/10.1172/JCI76012.

[38] Zhang S, Gang X, Yang S, et al. The alterations in and the role of the Th17/Treg balance in metabolic diseases. Front Immunol. 2021;12:678355. https://doi.org/10.3389/fimmu.2021.678355.

[39] Kidani Y, Bensinger SJ. Reviewing the impact of lipid synthetic flux on Th17 function. Curr Opin Immunol. 2017; 46:121-126. https://doi.org/10.1016/j.coi.2017.03.012.

[40] Zhao L, Wu Q, Wang X, et al. Reversal of abnormal CD4⁺ T cell metabolism alleviates thyroiditis by deactivating the mTOR/HIF1a/glycolysis pathway. Front Endocrinol (Lausanne). 2021;12:659738. https://doi.org/10.3389/fendo.2021.659738.

[41] Bommer GT, Van Schaftingen E, Veiga-da-Cunha M. Metabolite repair enzymes control metabolic damage in glycolysis. Trends Biochem Sci. 2020; 45(3):228-243. https://doi.org/10.1016/j.tibs.2019.07.004.

[42] Liu S, Liao S, Liang L, et al. The relationship between CD4⁺ T cell glycolysis and their functions. Trends Endocrinol Metab. 2023; 34(6):345-360. https://doi.org/10.1016/j.tem.2023.03.006.

[43] Okano T, Saegusa J, Nishimura K, et al. 3-Bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation. Sci Rep. 2017;7:42412. https://doi.org/10.1038/srep42412.

[44] Shi LZ, Wang R, Huang G, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011; 208(7):1367-1376. https://doi.org/10.1084/jem.20110278.

[45] Ye Z, Zeng Z, Shen Y, et al. ODC1 promotes proliferation and mobility via the AKT/GSKβ/β-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma. Onco Targets Ther. 2019; 12:4081-92. https://doi.org/10.2147/OTT.S198341.

[46] BEN-SAHRA I, DIRAT B, LAURENT K, et al. Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death. Cell Death Differ. 2013; 20(4):611-9. https://doi.org/10.1038/cdd.2012.157.

[47] Huang YF, Wang G, Ding L, et al. Lactate-upregulated NADPH-dependent NOX4 expression via HCAR1/PI3K pathway contributes to ROS-induced osteoarthritis chondrocyte damage. Redox Biol. 2023;67:102867. https://doi.org/10.1016/j.redox.2023.102867.

[48] Yang J, Dong C, Wu J, et al. Fructose utilization enhanced by GLUT5 promotes lung cancer cell migration via activating glycolysis/AKT pathway. Clin Transl Oncol. 2023; 25(4):1080-1090. https://doi.org/10.1007/s12094-022-03015-2.

[49] Luo SS, Li FF, Xie XQ, et al. Anti-inflammatory and hepatoprotective effects of andrographolide combined with methotrexate on rheumatoid arthritis rats. J Zhengzhou Univ. 2020; 55:472-475. https://doi.org/10.13705/j.issn.1671-6825.2019.07.074.

[50] Dey SK, Bose D, Hazra A, et al. Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives. PLoS One. 2013; 8(3):e58055. https://doi.org/10.1371/journal.pone.0058055.

[51] Toppo E, Darvin SS, Esakkimuthu S, et al. Effect of two andrographolide derivatives on cellular and rodent models of non-alcoholic fatty liver disease. Biomed Pharmacother. 2017; 95:402-411. https://doi.org/10.1016/j.biopha.2017.08.071.

[52] Zhao Y, Huang P, Chen Z, et al. Clinical application analysis of andrographolide total ester sulfonate injection, a traditional Chinese medicine licensed in China. J Huazhong Univ Sci Technolog (Med Sci). 2017; 37(2):293-299. https://doi.org/CNKI:SUN:TJYW.0.2017-02-022.